Volume 8 Supplement Q September 2012

Welcome to PCR London Valves 2012

• Thomas M,
• Windecker S

EuroIntervention 2012;8:Q7

PCR London Valves: a global course on valvular heart disease under the auspices of PCR and EAPCI

• Fajadet J

EuroIntervention 2012;8:Q9-Q11

Building on the shoulders of giants: the Valve Academic Research Consortium (VARC) initiative towards a global framework to guide valvular heart disease trials

• Serruys PW

EuroIntervention 2012;8:Q12-Q14

Historical perspective: 10th year anniversary of TAVI

• Cribier A

EuroIntervention 2012;8:Q15-Q17

Mechanisms and prediction of aortic regurgitation after TAVI

• Petronio A,
• Giannini C,
• De Carlo M

EuroIntervention 2012;8:Q18-Q20

Imaging and quantification of aortic regurgitation after TAVI

• Ewe S,
• Delgado V,
• Bax J

EuroIntervention 2012;8:Q21-Q30

Prognostic impact of aortic regurgitation after transcatheter aortic valve implantation

• Jilaihawi H,
• Makkar R

EuroIntervention 2012;8:Q31-Q33

Treatment and prevention of aortic regurgitation after transcatheter aortic valve implantation

• Hayashida K,
• Lefèvre T

EuroIntervention 2012;8:Q34-Q40

Paravalvular leaks: mechanisms, diagnosis and management

• Garcia E,
• Sandoval J,
• Unzue L,
• Hernández-Antolín R,
• Almería C,
• Macaya C

EuroIntervention 2012;8:Q41-Q52

Transcatheter mitral valve interventions: current status and future perspective

• Feldman T,
• Ali O

EuroIntervention 2012;8:Q53-Q59

Transcatheter aortic valve implantation and cerebrovascular accidents

• Stortecky S,
• Wenaweser P,
• Windecker S

EuroIntervention 2012;8:Q60-Q69

Boston Scientific Lotus valve

• Meredith I,
• Hood K,
• Haratani N,
• Allocco D,
• Dawkins K

EuroIntervention 2012;8:Q70-Q74

Direct Flow Medical valve

• Bijuklic K,
• Tübler T,
• Low R,
• Grube E,
• Schofer J

EuroIntervention 2012;8:Q75-Q78

Edwards CENTERA valve

• Ribeiro H,
• Urena M,
• Kuck K-H,
• Webb J,
• Rodes-Cabau J

EuroIntervention 2012;8:Q79-Q82

Edwards SAPIEN 3 valve

• Binder R,
• Rodes-Cabau J,
• Wood D,
• Webb J

EuroIntervention 2012;8:Q83-Q87

JenaValve

• Treede H,
• Rastan A,
• Ferrari M,
• Ensminger S,
• Figulla HR,
• Mohr F

EuroIntervention 2012;8:Q88-Q93

Medtronic CoreValve Evolut valve

• Sinning J-M,
• Werner N,
• Nickenig G,
• Grube E

EuroIntervention 2012;8:Q94-Q96

St Jude Medical Portico valve

• Manoharan G,
• Spence M,
• Rodes-Cabau J,
• Webb J

EuroIntervention 2012;8:Q97-Q101

Symetis ACURATE TA valve

• Kempfert J,
• Möllmann H,
• Walther T

EuroIntervention 2012;8:Q102-Q109

Transcatheter aortic valve replacement for severe aortic stenosis in elderly patients with severely depressed left ventricular function

Prognostic implications of moderate and severe mitral regurgitation in contemporary clinical care

Thirty-day outcomes after TAVI in patients with severe aortic stenosis and moderate or severe mitral regurgitation

Real-world European experience with the transcatheter treatment of significant mitral regurgitation: demographics and procedural outcomes

Transcatheter aortic valve implantation for pure severe native aortic regurgitation

Predictors of post-procedure paraprosthetic aortic regurgitation following self-expanding valve implantation: a multicentre registry analysis

Impact of post-procedural aortic regurgitation on mortality after TAVI

Percutaneous closure of paravalvular aortic leaks with the Amplatzer Vascular Plug III ®, late clinical follow-up

Effects of preoperative tricuspid regurgitation on mitral regurgitation treatment with the MitraClip device in high-risk patients

MitraClip repair for severe mitral regurgitation: initial Asian experience

Percutaneous closure of paravalvular mitral prosthetic regurgitation with the Amplatzer Vascular Plug III®

Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry

Impact of experience on TAVI outcome: a propensity-matched analysis from the pragmatic plus initiative

Is EuroSCORE II better than EuroSCORE in predicting mortality after transcatheter aortic valve implantation?

Comparison of new EuroSCORE II with logistic EuroSCORE and STS score in predicting 30-day and one-year mortality in patients undergoing TAVI

Comparison of EuroSCORE and EuroSCORE II in predicting short-term mortality in patients undergoing TAVI

Comparison of effectiveness and safety of TAVI in patients ≥90 years of age versus <90 years of age

Transcatheter mitral valve-in-valve/valve-in-ring implantations for degenerative post-surgical valves: results from the global valve-in-valve registry

The Swedish TAVI registry: all 566 procedures in 2008-2011

The Ibero-American Transcatheter Aortic Valve Implantation Registry: acute and long-term results

Initial experience with transfemoral implantation of the prosthesis Edwards SAPIEN XT without previous valvuloplasty in patients with severe aortic stenosis

Transcatheter valve-in-valve implantation in degenerated aortic bioprostheses via transfemoral access with the Edwards SAPIEN XT transcatheter heart valve

TAVI for patients with severe bicuspid aortic valve stenosis

Percutaneous transfemoral transcatheter aortic valve implantation (pTAVI): a single-centre experience comparing general with local anaesthesia

The European experience with the direct-aortic approach for a self-expandable transcatheter aortic bioprosthesis implantation

Transseptal antegrade transcatheter aortic valve replacement for no-access option patients. A contemporary experience

Transcutaneous aortic valve implantation using the left carotid access: feasibility and early clinical outcomes

Is the percutaneous femoral approach for TAVI always better? A comparison with a femoral surgical cut-down

One single centre’s short- and long-term outcomes after TAVI: no differences between the transfemoral and transapical approach

Balloon-expandable sheath for borderline vascular access in transfemoral TAVI

Predictive factors of successful repeat percutaneous mitral commissurotomy for mitral restenosis after previous percutaneous commissurotomy

Concept of the central clip: when to use one or two Mitraclips®

Incidence of permanent pacemaker implantation after TAVI and re-evaluation of the indications after the periprocedural period

Achieving a low pacing rate with CoreValve TAVI: high implantation, new delivery catheter, or both?

How does inflammation influence left ventricular function after TAVI?

Early and late changes in quality of life following TAVI using the transfemoral and transapical approaches

Emergency and prophylactic use of miniaturised veno-arterial extracorporeal membrane oxygenation (vaECMO) in transcatheter aortic valve implantation (TAVI)